Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
TOP STORIES — Diabetes News and Research
An Effective Treatment for Type 1 Using A Blood Pressure Medication
Lipid Profiling Can Predict the Risk of Diabetes and CVD Years Before Onset
Eating Habits and Their Impact on T2D Treatments
Can Caffeine be the Key to Fighting CVD?
Treating CVD with DPP-4 Inhibitors vs. Sulphonylureas Plus Metformin
Letter from the Editor
It is amazing how full drive-through windows are at coffee shops. It does not matter what time of day; there is always a line. There are people ordering plain coffee, lattes, and dozens of drinks I can’t even spell. What if in the future they could place an order for a CVD blocker?
This may occur sooner than you think, as our intern, Amanda Roberts, PharmD Candidate, Florida A&M University, has found some very interesting data on how caffeine can actually reduce the risk of CVD, and even lower LDL. Check out her feature here.
*****************************
We can make a difference!
*****************************
Dave Joffe
Editor-in-chief
TOP STORIES — Diabetes News and Research
Verapamil might serve as a potential breakthrough allowing type one diabetes patients to produce their insulin.
The analysis of lipid profiling in the prediction of risk of developing type 2 diabetes and cardiovascular diseases can aid in recommending lifestyle changes and diet before the development of the diseases.
Studies have shown that emotional eating and other eating behaviors could reduce weight loss when taking GLP-1 receptor agonists.
Studies have found that average levels of moderate caffeine intake are related to lower cardiovascular risk.
New retrospective study results compare the two most primarily prescribed antidiabetic medication classes in addition to metformin to determine the impact on the incidence of CV events in patients with T2DM.
According to the research presented by Dr. Petter Bjornstad from the University of Colorado Anschutz Medical Campus, the risk of microvascular complications increases by the time of young adulthood in patients who have diabetes in youth.
Diabetes in Control gratefully acknowledges the assistance of the following pharmacy doctoral candidates in the preparation of this newsletter:
Betsy Adegborioye, PharmD Candidate 2022, South College School of Pharmacy
Janet Falade, PharmD Candidate, South College School of Pharmacy
Kmeone Kingdom, MPH, PharmD Candidate, South College School of Pharmacy
Amanda Roberts, PharmD Candidate, Florida A&M University, College of Pharmacy and Pharmaceutical Sciences Institute of Public Health
Alexa Rodriguez, PharmD Candidate 2022, University of South Florida, Taneja College of Pharmacy
Your Friends in Diabetes Care
Steve and Dave
Diabetes In Control
www.diabetesincontrol.com